Evidence map›Paper›PMID 41413494›Full record

ArticleBMC pediatrics2025

Utilization and associated factors of second dose measles vaccine among mothers having a child less than two years old in Enderta District, South Eastern Tigray, Ethiopia.

Rigbe Teweldebrhan Gebrekidan, Abreham Habtemariam Weldu, Shishay Wahdey Teklemedhin, Haftamu Ebuy Teka, Haftom Gebrehiwot Misgna, Gebretsadik Kiros Lema, Mussie Alemayehu

Abstract read
In one paragraph

Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rigbe Teweldebrhan Gebrekidan *Department of Reproductive Health, School of Public Health, College of Health Sciences, Tigray Region, Mekelle University, P.O BOX:1871, Mekelle city, Ethiopia.
Abreham Habtemariam Weldu *Department of Reproductive Health, School of Public Health, College of Health Sciences, Tigray Region, Mekelle University, P.O BOX:1871, Mekelle city, Ethiopia. tsehaykidanea@gmail.com.ORCID 0009-0005-1675-2180
Shishay Wahdey Teklemedhin *Department of Reproductive Health, School of Public Health, College of Health Sciences, Tigray Region, Mekelle University, P.O BOX:1871, Mekelle city, Ethiopia.ORCID 0000-0002-1433-9457
Haftamu Ebuy Teka *Department of Reproductive Health, School of Public Health, College of Health Sciences, Tigray Region, Mekelle University, P.O BOX:1871, Mekelle city, Ethiopia.ORCID 0000-0001-7568-5444
Haftom Gebrehiwot Misgna *Department of Pediatric and Child Health, School of Nursing, College of Health Sciences, Tigray Region, Mekelle University, P.O BOX:1871, Mekelle city, Ethiopia.
Gebretsadik Kiros Lema *Department of Reproductive Health, School of Public Health, College of Health Sciences, Tigray Region, Mekelle University, P.O BOX:1871, Mekelle city, Ethiopia.ORCID 0000-0002-9871-9288
Mussie Alemayehu *School of Public Health, College of Health Sciences, Mekelle University, Mekelle, Ethiopia and Tigray Research Health Institute (THRI), Mekelle, Tigray, Ethiopia, 1871, Mekelle, Tigray, Ethiopia, Ethiopia.ORCID 0000-0002-0035-631X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to assess the utilization and associated factors of second-dose measles vaccine among mothers with children less than two years old in Enderta district, South Eastern Tigray.

methodsA mixed community-based cross-sectional study was conducted in Enderta district, South Eastern Tigray from January- to March 2020. The sample size of this study was 410 mothers, 10 in-depth interviews, and 2 focus group discussions. Multistage sampling technique for the quantitative data and purposive sampling for the qualitative data was used. Quantitative data were collected by the interviewer-administered questionnaires and entered and analyzed using Epi-data-3.1 and SPSS-20, respectively. Binary logistic regression analysis was done and adjusted odds ratios measured the strength of statistical association at 95% confidence interval. Variables with a P-value < 0.2 in the bivariate analysis were entered into multivariable analysis statistical significance was declared at P-value < 0.05. Thematic analysis was employed for the qualitative data. After the qualitative data was coded, themes were developed. The result of the qualitative data was presented and discussed by triangulating.

resultUtilization of second dose measles-containing vaccine was 32.4%. Top reasons for not vaccinating second dose measles-containing vaccines to their children were: lack of awareness about the necessity of the vaccine, missing the appointment date, mother being too busy and absence of vaccine supply. In the multivariable analysis; children aged 18-23 months (AOR 0.5; CI (0.3-0.8)), number of children greater than five per family (AOR 2.3; CI (1.3-4.3)), type of health facility (AOR 1.7; CI (1.05-2.9)), children with a history of completed basic vaccines at 12 months (AOR 2.6; CI (1.5-4.3)) and knowledgeable mothers (AOR 1.67; CI (1.04-2.7)) were significantly associated with the taking of second dose measles vaccine of their last child.

conclusionDespite the slight improvement from the regional and national Ethiopian Demographic Health Survey reports, utilization of second dose measles vaccine in this study was low.

Indexed as

MeaslesMeasles VaccineMothersPatient Acceptance of Health CareAdolescentAdultCross-Sectional StudiesEthiopiaFemaleFocus GroupsHumansInfantMaleYoung AdultMeasles VaccineAssociated factorsChildren less than two years oldEthiopiaMeasles containing vaccineTigray

Identifiers

PMID41413494
PMCPMC12853861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.